Cell-cell Fusion of Genome Edited Cell Lines for Perturbation of Cellular Structure and Function
December 7th, 2019
8.8K views
The purpose of this protocol is to fuse two different cell types to create hybrid cells. Fluorescence microscopy analysis of fused cells is used to track the cell of origin of cellular organelles. This assay can be used to explore how cellular structure and function respond to perturbation by cell fusion.
Overview
This protocol describes the fusion of two different cell types to create hybrid cells, allowing for the analysis of cellular structure and function. Fluorescence microscopy is employed to track the origin of cellular organelles in the fused cells.
Key Study Components
Area of Science
- Cell Biology
- Fluorescence Microscopy
- Cell Fusion Techniques
Background
- Cell fusion can perturb cellular structure and function.
- Understanding organelle homeostasis is crucial for cellular biology.
- Fluorescent tagging allows for tracking of organelles back to their cell type of origin.
- This method can help address questions about cellular responses to changes.
Purpose of Study
- To create hybrid cells from different cell types.
- To explore how cellular structures respond to perturbations.
- To study mechanisms of organelle function and homeostasis.
Methods Used
- Fusion of rootletin eGFP and rootletin-mScarlet cells.
- Fluorescent dye labeling of cells prior to fusion.
- Microscopy analysis to observe cellular structures.
- Tracking of organelles to their cell type of origin.
Main Results
- Successful creation of hybrid cells through fusion.
- Fluorescent labeling enabled tracking of organelles.
- Insights into how cells respond to changes in organelle number.
- Demonstrated the utility of fluorescence microscopy in cell biology.
Conclusions
- Cell fusion is a valuable technique for studying cellular dynamics.
- Fluorescence microscopy provides critical insights into organelle function.
- This method can advance understanding of cellular responses to perturbations.
Frequently Asked Questions
What is the purpose of cell fusion in this study?
The purpose is to create hybrid cells to study how cellular structures respond to perturbations.
How are the cells labeled for fluorescence microscopy?
Cells are labeled with Violet and Far Red dyes before fusion.
What can be learned from tracking organelles in fused cells?
It helps in understanding organelle homeostasis and cellular responses to changes.
What types of cells are used in this protocol?
Rootletin eGFP and rootletin-mScarlet cells are used for fusion.
What is the significance of using fluorescence microscopy?
It allows for detailed visualization and tracking of cellular structures and organelles.
Executive Industry Relevance
Cell fusion enables perturbation of cellular architecture to interrogate organelle homeostasis and functional responses, providing a mechanistic de-risking approach for target validation in early discovery. By tracking fluorescently tagged proteins to their cell of origin, the method supports predictive confidence in pathway modulation and phenotypic screening outcomes. This approach addresses discovery-stage challenges in understanding subcellular dynamics relevant to therapeutic hypothesis testing.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by perturbing organelle number and observing functional consequences in hybrid cells.
- Operational Value: Provides a reproducible system for functional target validation through direct visualization of organelle mixing and centrosome doubling.
- Predictive Value: Supports portfolio triage by linking structural perturbations to functional readouts via fluorescence microscopy.
Screening & Assay Development
- Scientific Value: Generates quantifiable hybrid cell populations enriched by FACS for consistent assay inputs in compound screening.
- Operational Value: Standardizes fusion efficiency and double-positive gating to ensure assay reproducibility across runs.
- Scalability: Enables platform reuse across different cell types and organelles of interest for broad target engagement studies.
Translational & Preclinical Research
- Translational Continuity: Bridges discovery observations of organelle homeostasis to preclinical models by enabling mechanistic de-risking of targets involved in subcellular dynamics.
- Predictive De-risking: Allows assessment of how genetic or pharmacological perturbations affect organelle number and function in a controlled hybrid system.
- Disease Relevance: Applicable to fundamental questions in organelle regulation relevant to neurodegenerative, oncological, and metabolic disease pathways.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target hypothesis testing through lead identification, enabling mechanistic insight before compound progression.
- Discovery Biology: Supports hypothesis testing by allowing direct observation of how changes in organelle number affect cellular function in a defined genetic background.
- Screening: Delivers assay-ready hybrid cells with standardized fluorescence signatures for reliable compound-induced phenotypic evaluation.
- Analytics: Provides quantitative dependent variable measurements such as centrosome count and organelle colocalization to compare experimental conditions.
- Translational Research: Connects early discovery findings to preclinical continuity by establishing causal links between target modulation and subcellular structural outcomes.
- Enterprise Reuse: Functions as a reusable capability for probing organelle homeostasis across multiple targets and therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by enabling direct correlation of organelle perturbations to functional readouts via origin-tracked fluorescence.
- Operational Value: Ensures standardization through FACS-based enrichment of double-positive fused cells and controlled PEG-mediated fusion timing.
- Strategic Value: Improves go/no-go decisions by providing early structural-functional data that de-risks targets involved in organelle homeostasis.
- Portfolio Impact: Supports risk-adjusted advancement by validating target effects on subcellular architecture before preclinical investment.
Implementation Considerations
- Requires expertise in cell culture, fluorescent labeling, and flow cytometry for accurate cell fusion and enrichment.
- Dependent on fluorescence microscopy infrastructure capable of multi-channel imaging and 3D image acquisition.
- Necessitates cross-team standardization of dye labeling protocols and FACS gating strategies for reproducible hybrid cell isolation.
- Adaptation considerations include optimizing PEG concentration and incubation time for different cell types to avoid cytotoxicity.
- Practical limitations include variability in fusion efficiency and the need for validation of organelle markers in each cell line of interest.
Biopharma FAQs
Why does FACS enrichment of double-positive cells matter for target validation?
FACS enrichment ensures isolation of bona fide heterokaryons by gating on cells positive for both Violet and Far Red dyes, eliminating false positives from dye transfer or incomplete fusion. This purification step is critical for reliable downstream imaging and functional analysis, directly supporting confident interpretation of organelle mixing and centrosome doubling in target validation studies.
How does isolating the independent variable of organelle number fit the discovery pipeline?
By fusing cells with known differences in organelle content, the method allows controlled increase in organelle number as an independent variable to observe functional consequences. This enables hypothesis testing in early discovery by linking a defined structural perturbation to downstream phenotypic readouts, fitting within the target validation stage before compound screening.
What quantitative dependent variable measurements enable mechanistic de-risking?
Quantitative measurements include centrosome number (via NEDD1 foci), organelle colocalization, and fluorescence intensity ratios that distinguish origin-specific signals in fused cells. These readouts provide objective, comparable data to assess how genetic or pharmacological perturbations affect subcellular structure, enabling mechanistic de-risking of targets involved in organelle homeostasis.
Why do replication requirements matter for cross-functional collaboration?
Replication requires consistent PEG-mediated fusion timing, dye labeling efficiency, and FACS gating to produce comparable hybrid cell yields across experiments and laboratories. Standardization of these parameters ensures that imaging and functional data are reproducible, enabling reliable handoff between discovery biology, assay development, and preclinical teams for aligned decision-making.
What statistical analysis capabilities are required before implementing this method in a screening workflow?
Before implementation, teams must establish baseline fusion efficiency, define significance thresholds for centrosome doubling or organelle shifts, and apply appropriate statistical tests (e.g., t-test or ANOVA) to compare control and experimental hybrid populations. These capabilities ensure that observed changes in cellular structure are statistically robust and not due to technical variability, supporting confident go/no-go decisions in lead identification.
